These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23314247)

  • 1. Tacrolimus in the management of hospitalized patients with steroid-refractory ulcerative colitis: don't forget cytomegalovirus!
    Roblin X; Del Tedesco E
    Inflamm Bowel Dis; 2013 Apr; 19(5):E67-8. PubMed ID: 23314247
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcineurin inhibition in severe ulcerative colitis: lost in translation?
    Annunziata ML; Hanauer SB
    Inflamm Bowel Dis; 2012 May; 18(5):809-11. PubMed ID: 21837776
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis.
    Ogata H; Kato J; Hirai F; Hida N; Matsui T; Matsumoto T; Koyanagi K; Hibi T
    Inflamm Bowel Dis; 2012 May; 18(5):803-8. PubMed ID: 21887732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to Roblin and Del Tedesco.
    Ogata H
    Inflamm Bowel Dis; 2013 Apr; 19(5):E68. PubMed ID: 23538853
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children.
    Ziring DA; Wu SS; Mow WS; Martín MG; Mehra M; Ament ME
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):306-11. PubMed ID: 17873742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium to long-term efficacy and safety of oral tacrolimus in moderate to severe steroid refractory ulcerative colitis.
    Olmedo Martín RV; Amo Trillo V; González Grande R; Jiménez Pérez M
    Rev Esp Enferm Dig; 2017 Aug; 109(8):559-565. PubMed ID: 28617029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients.
    Miyoshi J; Matsuoka K; Inoue N; Hisamatsu T; Ichikawa R; Yajima T; Okamoto S; Naganuma M; Sato T; Kanai T; Ogata H; Iwao Y; Hibi T
    J Crohns Colitis; 2013 Dec; 7(12):e609-14. PubMed ID: 23680174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis.
    Farkas K; Molnár T; Szepes Z
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):695-702. PubMed ID: 24738535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis.
    Watson S; Pensabene L; Mitchell P; Bousvaros A
    Inflamm Bowel Dis; 2011 Jan; 17(1):22-9. PubMed ID: 20722055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sweet syndrome and erythema nodosum in ulcerative colitis, refractory to steroids: successful treatment with tacrolimus].
    Fellermann K; Rudolph B; Witthöft T; Herrlinger KR; Tronnier M; Ludwig D; Stange EF
    Med Klin (Munich); 2001 Feb; 96(2):105-8. PubMed ID: 11253280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis.
    Baumgart DC; Sturm A; Wiedenmann B; Dignass AU
    Gut; 2005 Dec; 54(12):1822-3. PubMed ID: 16120758
    [No Abstract]   [Full Text] [Related]  

  • 14. Tacrolimus Therapy in Steroid-Refractory Ulcerative Colitis: A Review.
    Wu B; Tong J; Ran Z
    Inflamm Bowel Dis; 2020 Jan; 26(1):24-32. PubMed ID: 30980713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IBD. Sequential rescue therapy in steroid-refractory ulcerative colitis.
    Gionchetti P; Rizzello F
    Nat Rev Gastroenterol Hepatol; 2014 Sep; 11(9):521-3. PubMed ID: 25023033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: don't forget the role of cyclosporin.
    Sinagra E; Orlando A; Renna S; Maida M; Cottone M
    Inflamm Bowel Dis; 2012 Aug; 18(8):E1594-5. PubMed ID: 22038892
    [No Abstract]   [Full Text] [Related]  

  • 18. Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment.
    Boschetti G; Nancey S; Moussata D; Stefanescu C; Roblin X; Chauvenet M; Stroeymeyt K; Bouhnik Y; Flourié B
    Dig Liver Dis; 2014 Oct; 46(10):875-80. PubMed ID: 25023007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is cytomegalovirus really a cause of resistance to steroids in ulcerative colitis?
    Roblin X; Bonaz B
    Dis Colon Rectum; 2005 Jan; 48(1):174; author reply 174-5. PubMed ID: 15690679
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ulcerative colitis, tacrolimus and mucosa remission].
    Barrio J; Atienza R; Julián-Gómez L; Gil-Simón P; García-Pajares F; Caro-Patón A
    Gastroenterol Hepatol; 2008 Dec; 31(10):711-3. PubMed ID: 19174087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.